NFKB1 and cancer: Specifically, the process of IκB degradation illustrates how NF-κB activity is finely tuned in response to inflammatory stimuli, which can either protect against or contribute to the pathogenesis of cancer, depending on the cellular context and the nature of the inflammatory response.